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Abstract
There is a significant gap in our fundamental understanding of early morphological and migratory changes in human
Langerhans cells (LCs) in response to vaccine stimulation. As the vast majority of LCs studies are conducted in small animal
models, substantial interspecies variation in skin architecture and immunity must be considered when extrapolating the
results to humans. This study aims to determine whether excised human skin, maintained viable in organ culture, provides a
useful human model for measuring and understanding early immune response to intradermally delivered vaccine
candidates. Excised human breast skin was maintained viable in air-liquid-interface organ culture. This model was used for
the first time to show morphological changes in human LCs stimulated with influenza virus-like particle (VLP) vaccines
delivered via intradermal injection. Immunohistochemistry of epidermal sheets and skin sections showed that LCs in VLP
treated skin lost their typical dendritic morphology. The cells were more dispersed throughout the epidermis, often in close
proximity to the basement membrane, and appeared vertically elongated. Our data provides for increased understanding of
the complex morphological, spatial and temporal changes that occur to permit LC migration through the densely packed
keratinocytes of the epidermis following exposure to vaccine. Significantly, the data not only supports previous animal data
but also provides new and essential evidence of host response to this vaccination strategy in the real human skin
environment.
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Introduction
Intradermal (ID) delivery of vaccines has been shown to induce
protective immunity against many diseases, including hepatitis B
[1,2], rabies [3], tuberculosis [4], measles [5], polio [6] and
influenza [7,8]. ID vaccination aims to exploit the abundance of
antigen presenting cells (APCs) found within the skin; that is dermal
dendritic cells (DDCs) in the dermis and LCs in the epidermis. Both
these cell types have the ability to uptake, process and present both
self- and foreign antigens to naı ¨ve T-cells [9] following migration to
the lymphatics, and therefore have the potential to elicit an adaptive
immune response [10]. Administration of vaccines by the ID route
therefore aims to target these cell types (Figure 1) to provide a more
proficient immune response, potentially at reduced dose [11].
Whilst we acknowledge the potential importance of both of these
cell types in generating an immune response, in this study we will
focus solely on epidermal LCs as the most accessible and easily
monitored dendritic cell (DC) subtype.
LCs comprise approximately 3–5% of the nucleated cells in the
epidermis [12] and possess a typical DC morphology [13], with
numerous cytoplasmic processes penetrating the intracellular
regions between keratinocytes (Figure 1C). LCs are found in
sufficient numbers to form a complete network across the entire
skin surface with the dendrites from individual LCs extending out
from the cell body in parallel to the basement membrane. LCs are
generally observed towards the centre of the epidermis (stratum
spinosum), surrounded on all sides by keratinocytes. The
migratory nature of antigen-stimulated LCs has been well
characterized in rodent models, providing insight into the
behavior of this cell type [14,15]. LC activation and migration
has been shown to depend on differing levels of cytokines and
chemokines produced by the LCs themselves and the surrounding
keratinocytes. Principle cytokines in this respect are interleukin-1b
(IL-1b), tumor necrosis factor-a (TNF-a), and interlukin-18 (IL-18)
[16]. Upon activation, LCs negotiate a path through the
surrounding keratinocytes and migrate across the epidermal/
dermal junction. During transit, antigen-activated LCs mature,
resulting in a reduced ability to process subsequently encountered
antigen and an increase in immuno-stimulatory capabilities [17].
The ultimate destination of actively migrating LCs is the
paracortical regions of lymphatic nodes where presentation of
peripherally acquired antigen to naı ¨ve T-cells occurs [13].
PLoS ONE | www.plosone.org 1 August 2010 | Volume 5 | Issue 8 | e12410Although there are some reports investigating the immunological
role and migratory nature of human LCs [18,19], the vast majority of
LCs studies have been conducted in small animal models, principally
the mouse [20–22]. As a corollary, substantial interspecies variation in
skin architecture and immune response must be taken into
consideration when extrapolating these data to the situation in
humans [23]. In particular, despite numerous clinical studies reporting
ID administration with influenza vaccines [24–30], there is a
significant gap in our understanding of the initial events that occur
in human skin. Since LCs reside in the epidermis, their accessibility
provides a unique opportunity to study a subset of APC in their native
environment. This study utilizes a previously established ex vivo human
skinorganculture system[31] to examine the earlymorphological and
behavioral changes of human LCs in response to a promising vaccine
candidate; influenza virus-like particles (VLPs) [32–35]. Using this
model of real human skin, we aim to provide unique mechanistic
information relating to the poorly defined sequence of events
occurring immediately following LCs contact with vaccine antigens
that lead to trafficking of the LCs to the lymphatic system. While this
kind of study of human LCs would be difficult in human patients, the
use of cultured human skin explants provides a unique opportunity to
monitor these events in a controlled environment. An increased
understanding of antigen-induced activation and migration of LCs in
human skin tissue will serve to complement animal and human ID
vaccine studies, providing a meaningful data set to inform pre-clinical
and clinical vaccine development.
Results
Changes in LCs numbers following ID injection of H1 VLP
vaccines
On excision and subsequent culture of human skin, LCs will
inevitably begin to migrate from the epidermis due to physical and
chemical changes in the tissue resulting in the propagation of
migratory signals [15,31,36]. This non-antigen mediated depletion
in LCs numbers in epidermal sheets is apparent in untreated
human skin samples (Figure 2B) and as such represents the
baseline against which LCs changes in skin samples in response to
injected vaccine can be measured.
Following ID injection of influenza H1 VLP vaccine, a more
pronounced effect on the number of LCs in epidermal sheets was
observed. Epidermal membranes prepared 24 hours after injection
with HI VLPs were observed to contain significantly (P,0.001)
lower numbers of LCs compared to untreated skin samples at the
same time point (Figure 2A). The more marked reduction in LCs
numbers was also obvious 48 hours after treatment. The number
of LCs in epidermal sheets taken from skin samples injected with
PBS alone did not differ from untreated skin samples. Represen-
tative images of epidermal sheets are displayed in Figure 2B. The
images serve to reflect the significant reduction in LCs numbers
observed when skin is injected with H1 VLPs compared with
blank skin and skin injected with PBS alone. These data provide
clear evidence that LCs in excised human skin migrate from a
given optical plane of the epidermis in greater numbers following
ID injection of H1 VLPs compared to control skin. We now aim to
further explore the nature of LC response to VLP vaccine in
human skin.
Changes in LCs morphology following ID injection with
H1 VLP vaccines
During the microscopic analysis of cell numbers in epidermal
sheets, on closer inspection we observed that LCs underwent vivid
changes in cell morphology, particularly following treatment with
VLPs. Populations of LCs formed single, extremely long dendrites
(Figure 2C), so termed a ‘‘hyper-dendritic’’ morphology. Addi-
tionally, a considerable proportion of LCs did not have any surface
Figure 1. Rationale for intradermal (ID) vaccine delivery. (A) ID delivery of H1 VLPs to excised human skin using the Mantoux method. A 26G
hypodermic needle was inserted laterally into the skin followed by injection of H1 VLP suspension (10mg VLP). A characteristic wheal, typical of ID
injection,isclearlyvisible.(B)IHCstained(CD207)humanepidermalsheetshowingtheextensivenetworkcharacteristicofLCs.(C) AsingleLCdisplaying
the typical dendritic cell nature of this cell type. Dendrites emanating from the LC body can clearly be seen infiltrating between individual keratinocytes.
doi:10.1371/journal.pone.0012410.g001
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‘‘rounded’’ morphology. Frequently, both hyper-dendritic and
rounded LCs were observed in close proximity (Figure 2E),
indicating that individual cells within defined regions, were
responding either differently or at different rates from one another
in response to administered vaccine. It was noted that these
morphological changes were greatly more pronounced in skin
treated with H1 VLPs with both hyper dendritic and rounded LCs
constituting a larger proportion of the overall LC population
compared to untreated skin.
LCs dendrite morphology
In an attempt to quantify the aforementioned morphological
changes observed in LCs as a consequence of exposure to H1
VLPs, the numbers of dendrites emanating from individual LCs
were calculated. The typical appearance of LCs found in
epidermal sheets isolated from untreated ex vivo human skin
approximately 1.5 hours post surgery (the time at which ex vivo skin
organ culture begins) is shown as an example in Figure 3A. In this
image one of the LCs (i) has a total of four dendrites protruding
from the cell body (white arrows); while the other (ii) has a total of
five dendrites (red arrows). When dendrite numbers per LC were
calculated in untreated excised human skin in this way, it was
observed that a ‘typical’ LC had on average four dendrites/cell
(mean=3.8; median=4). The number of dendrites/cell assumes a
normal distribution around this mean value with some LCs having
as many as six dendrites and some as few as two (Figure 3B).
The dendritic appearance of LCs in untreated ex vivo human skin
changed as the cells responded to the culture environment
(Figure 3C and 3D). A general trend toward less dendrites/cell
was observed following 24 hours tissue culture (mean=2.466;
median=3), providing a baseline value for observations of treated
samples at that time point. Skin treated with H1 VLPs administered
by ID injection showed a greater reduction in dendrite numbers at
24 hours (mean=1.252; median=1) compared to untreated skin
(Figure 3C). Whilst untreated skin samples showed further
reductions in dendrite number/LC at 48 hours, the samples
exposed to H1 VLPs were again shown to contain cells with even
Figure 2. Changes in LC numbers and morphology in epidermal sheets. Human epidermal sheets were isolated from untreated cultured
skin and cultured skin treated by ID injection of PBS (control) or H1 VLPs. (A) Epidermal sheets were stained for CD207 and positively stained cells
were counted. Data presented as the percentage of CD207+ve cells (LCs) relative to cell numbers in untreated skin at each timepoint. Skin treated by
ID delivery of PBS (grey bars); Skin treated by ID delivery of H1 VLPs (white bars); data presented as mean 6 SD (n=4), significance was determined
relative to untreated skin at each timepoint (***p,0.001). (B) Representative images of LCs (CD207+ve cells) taken from each time point and
treatment (bar=20mm). (C) LCs displaying a ‘‘hyper-dendritic ‘‘cell morphology. (D) LCs displaying ‘‘rounded’’ cell morphology. (E) Both hyper-
dendritic and rounded LCs observed in the same optical plane of the epidermis (bar=10mm all cases).
doi:10.1371/journal.pone.0012410.g002
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LCs in untreated blank skin still maintained a degree of dendritic
morphology (mean=1.490; median 1.5); however cells displaying
dendritic morphology were much less apparent in skin treated with
H1 VLP via ID injection (mean=0.650; median=0).
Area of LCs in epidermal sheets
En face images captured at high magnification (6100) were used
to determine the mean area occupied by individual LCs within
epidermal sheets (Figure 4). In blank, untreated skin samples no
significant difference was observed in mean LC area between skin
samples at 1.5 hours post-surgery and at 24 hours in organ
culture. However, at 48 hours there was a significant reduction in
individual LC area (p,0.05) as the skin responds to prolonged
organ culture. At 24 hours the mean LC area in samples treated
with H1 VLP by ID injection was significantly reduced (p,0.05)
compared to untreated, blank skin (Figure 4). Interestingly, and
contrary to untreated samples, mean LC area in VLP treated
samples remained virtually unchanged between 24 and 48 hours,
possibly suggesting that the immune stimulatory effects of H1 VLP
vaccines occur in the first 24 hours after administration.
Area, morphology and distribution of LCs in sections
Following assessments of LC morphology in a single horizontal
plane, i.e. in epidermal sheets, further experiments were
conducted to investigate changes in LC morphology and
distribution throughout the vertical skin strata. In the first analysis
the total area occupied by LCs as a percentage of total epidermal
area was determined following image analysis of skin sections. In
transverse sections of untreated skin the area occupied by LCs
remains relatively consistent over the culture period (0–48 hours;
Figure 5A). The sections reveal LCs to be typically rounded and
well dispersed throughout the epidermis, with no noticeable
overlapping of cells (Figure 5B,C). In contrast, sections of skin
following ID injection of H1 VLP vaccines showed significant
changes in total area occupied by LCs (P,0.01), LC morphology
and LC distribution pattern. LC area in skin sections prepared
24 hours post-injection of VLPs was approximately doubled
(Figure 5A). The spatial distribution of LCs in these samples was
also noticeably different to blank skin at the same time points. For
example, Figure 5C and D show representative sections of
untreated skin and H1 VLP treated skin respectively at 24 hours.
The LCs in the H1 VLP treated samples (Figure 5D) appeared to
be more dispersed though the epidermis and less uniform in
distance from one another. Frequently, LCs were observed to be
distributed on top of each other, whereby one LC was typically
located toward the centre of the epidermis with another in close
proximity to the basement membrane (Figure 5D). This
distribution pattern was not observed in blank skin (Figure 5C).
At 48 hours the total area occupied by LCs in skin sections had
Figure 3. Number of dendrites per LC in epidermal sheets. (A) Microscopic examination revealed each LC to have a distinct cell body from
which dendrites protruded (bar=10mm). Two individual LCs designated (i) and (ii) with 4 and 5 dendrites per cell, indicated by the white and red
arrows, respectively. Percentage frequency of dendrites per LC in (B) pre-cultured epidermal sheets and post-cultured epidermal sheets at 24 (C) and
48 (D) hours; untreated skin (black bars), skin treated with H1 VLPs delivered by ID injection (white bars). Data presented as mean 6 SEM (n=8).
doi:10.1371/journal.pone.0012410.g003
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significant difference observed between blank and treated samples
(Figure 5A).
The transverse sections of H1 VLP treated skin samples in
Figure 5D show that LCs appeared to be vertically elongated
following vaccine administration. A clear example of a single LC
displaying this elongated morphology is shown in Figure 6A. A
more detailed analysis of individual and mean LC distance from
the epidermal membrane as observed in histological sections is
presented in Figure 6B. The mean LC distance from the
epidermal membrane is markedly reduced following ID injection
of H1 VLPs, this being particularly noticeable at the 24 hours time
point.
Figure 5D previously showed the presence of CD207+ve cells
located in the dermis. Figure 6C provides an image of another
section of skin injected with H1 VLPs 24 hours earlier. Whilst the
majority of CD207+ve cells, many of which are elongated, appear
in the epidermis, a small number of cells can also be seen beneath
the epidermal membrane (see arrows) in this section. CD207+ve
cells were very rarely observed in the dermis in blank skin samples.
Whilst in this paper we focus on LC behavior in human epidermis
we feel this additional observation of CD207+ve cells in the dermis
warrants a further human skin study aimed at tracking antigen-
associated changes to immune-responsive cells from epidermis to
dermis to lymph vessel.
Discussion
Recent studies have demonstrated that influenza VLPs, as a
particulate antigen mimicking native virions structurally and
morphologically, confer 100% protection in mice even after a
single dose vaccination [32,37]. We have also observed that the
H1 VLPs used in this study were highly immunogenic and
conferred protection after a single dose of ID injection in an
animal model (data not shown). More importantly, influenza VLPs
showed an equivalent or better efficacy compared to traditional
influenza vaccines in a recent clinical trial [38] indicating that
influenza VLPs can be a clinically important vaccine candidate.
For the first time, the current study aims to demonstrate that
influenza VLPs, as a relevant vaccine candidate, delivered via ID
injection, have a stimulatory effect on live, functional human DCs
in the biologically relevant environment of viable human skin.
DCs are highly proficient at uptaking, processing and presenting
antigenic material from the surrounding milieu to naive, antigen
specific T-cells within the nodes of the draining lymphatic system
[14]. LCs are peripheral DCs that therefore have to migrate from
the site of antigen uptake to present the antigen to T-cells. The
focus of this study was to observe and monitor LCs behavior in
viably maintained excised human skin following ID injection of
influenza H1 VLP vaccines. The data presented in this paper was
obtained by injecting two donor skin samples with a single batch of
H1 VLPs. The morphological and spatial changes we observe
however generally reflect other studies we have performed using
different delivery methods [39] and VLP strains (manuscript in
preparation).
Previous studies have demonstrated the properties of LCs in
skin organ culture [31,39,40,41] and their responses to changes in
pH, oxygen levels, damage generated by excision, excess hydration
and accumulation of waste products. Despite these changes in LCs
caused by changes in their environment, our work suggests that a
48 hour window exists in which to investigate the early stages of
LC activation and migration in response to antigen exposure.
Freshly excised human skin was maintained viable in organ culture
following ID injection of H1 VLP vaccine. Untreated skin and skin
injected with PBS alone were also cultured as controls. Following
skin incubation at air-liquid interface for 24 or 48 hours epidermal
sheets were generated and stained for CD207 to identify and
quantify LCs populations. The number of LCs observed in
epidermal sheets depleted significantly more rapidly when skin had
been treated with H1 VLPs delivered via ID injection, compared
to blank skin and PBS control, confirming LC migration in
response to ID vaccine delivery. The fact that a 10ml injection of
PBS alone failed to reduce LC numbers any more than untreated
controls, and that VLP administration via minimally invasive
microneedles has also been shown to reduce LC numbers [39],
suggests that the observed changes in LC response are due to
antigenic stimulation rather than any inflammation or trauma
caused by the administration procedure. This study reports for the
first time the observation that vaccination with VLPs via ID
injection can stimulate the migration of LCs from the human skin
epidermis.
In order for antigen-stimulated LCs to migrate, a number of
morphological changes need to occur. In intact normal skin
viewed en face, LCs spread over the body surface forming a
network with many characteristic dendritic protrusions, as
observed in pre-cultured skin samples. Migration of the LC to
the lymphatic vessels in the dermis requires the cell to negotiate a
tortuous path through the tightly packed keratinocytes resident in
the epidermis. In the unstimulated state the highly dendritic
morphology of the LC would restrict the movement between
epidermal keratinocytes. It is proposed that LCs displaying highly
dendritic morphologies are indicative of stationary, non-motile
cells. In order to aid physical movement through the epidermis,
LCs must therefore retract their dendrites upon antigen stimula-
tion and this should be apparent when viewed en face. Results from
this study showed that when skin was treated with H1 VLP
vaccines a more pronounced reduction in dendrites per LC was
observed, when compared with untreated skin at 24 and 48 hours.
Indeed, direct en face observation of epidermal sheets at these time
points revealed that H1 VLP treated samples contained high
proportions of LCs with retracted dendrites, thus displaying a
‘‘rounded’’ morphology. Also present, in considerable numbers in
Figure 4. Area of individual LCs in epidermal sheets. The mean
individual LC area (n=100) was determined using ImageJ software
following culturing of blank skin (black bars) and skin treated with H1
VLP delivered by ID injection (white bars). Data presented as mean 6
SD (n=4); significance was determined relative to blank skin at
corresponding time points (*p,0.05).
doi:10.1371/journal.pone.0012410.g004
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sion. According to a study performed by Swetman et al., 2002,
using an in vitro DC model, in order for DCs to move, an initial
point of attachment is made to the extra-cellular matrix, and then
the cell body moves away from this point leaving behind a long,
filamentous dendrite, in a process known to be dependent on Rho
GTPase [42]. With regard to the present study, this suggests that
LCs displaying highly elongated hyper-dendritic morphologies
were likely to be actively in the process of migrating through the
epidermis toward the basement membrane in response to antigen;
similar morphological and spatial observations being observed in
the mouse following LCs stimulation [22].
Image analysis of the CD207 stained epidermal sheets revealed
that as the number of dendrites reduced, during retraction, the
individual cell area also reduced. In contrast, when skin samples
were examined in histological sections, at equivalent time points,
there was a noticeable increase in total LCs area at 24 hours.
Rather than contradicting the changes in LC number and
individual LC area seen in epidermal sheets, this can be
rationalised in light of LC migration events. In order to migrate,
dendrites have to be retracted, resulting in a decrease in individual
cell area when viewed en face. Subsequent movement of the cell
towards the basement membrane results in a visible reduction in
LC number in the optically narrow horizontal plane of an epidermal
sheet yet an increase in total cell area in the vertical plane of an
epidermal section. Indeed, results from this study showed that
24 hours after VLP vaccine treatment individual LC area was
halved when viewed en face yet total cell area was doubled in
transverse section, strongly supporting the hypothesis that
morphological changes in LCs are induced differentially through
migration upon antigenic stimulation. That is, prior to migration
LCs are elongated horizontally, with respect to the skin surface,
but upon migration become elongated vertically, with respect to
the skin surface. Histological sections of skin prepared 24 hours
following treatment with H1 VLPs showed that the LCs were
much more dispersed throughout the epidermis, with many cells
occupying positions proximal to the basement membrane. In these
samples, cells were frequently observed vertically elongated with
respect to the skin surface, suggesting downward movement of the
cell toward the basement membrane. Indeed, there is also
Figure 5. Relative area and spatial distribution of LCs in histological sections. (A) The relative area of CD207+ve cells as a percentage of
total epidermal area in skin sections was determined using ImageJ software. Data presented as mean 6 SD (n=4) significance was determined
relative to blank skin at each corresponding time point (*p,0.05, **p,0.01, ***p,0.001). Skin sections showing spatial distribution of LCs in
histological skin sections: untreated skin at 0 hours (B), untreated skin at 24 hours (C) and skin treated with H1 VLPs delivered by ID injection at
24 hours (D). Bar=50mm in all cases.
doi:10.1371/journal.pone.0012410.g005
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into the dermis towards the lymphatic drainage system. The area
occupied by remaining epidermal LCs, in histological sections,
returned to approximately pre-culture values at 48 hours, which
likely reflect a population of LCs that for either unknown specific
biological reasons or insufficient or inappropriate stimulation fail
to migrate. This has been observed and documented elsewhere
where subsequent to antigen stimulation and initial migration a
population of LCs remained and failed to migrate even following a
second antigen application [43].
A schematic hypothesis summarizing the observed migratory
processes is shown in Figure 7. It is proposed that in response to
antigen-induced stimulation LCs begin to retract their dendrites
from the horizontal plane and take on a rounded appearance. This
provides a point of focus from which the LCs can begin to
negotiate a path down and between the tightly packed keratino-
cytes immediately below. From this rounded state, the LC
extrudes a single, exploratory dendrite in between the keratinoc-
tyes, toward the basement membrane. As the exploratory dendrite
forges a path between keratinocytes, the LC becomes elongated,
extending into the hyper-dendritic morphology described previ-
ously. As the antigen stimulated LC approaches the basement
membrane the cell once again ‘‘rounds up’’, before traversing the
membrane and continuing into the dermis.
In summary, ID injection of H1 VLP vaccines into ex vivo
human skin explants induced a marked biological response in
endogenous LCs. It appeared as if human LCs followed a
predetermined sequence of morphological changes in response to
the delivered vaccine, which ultimately ended in significant
numbers of cells migrating through and out of the epidermis.
Considerable knowledge regarding the activation and migratory
nature of LCs has previously been gained from the use of animal
Figure 6. LCs localization to epidermal basement membrane. (A) IHC stained (CD207) histological section showing a single LC extending an
exploratory dendrite toward the basement membrane; dashed line indicates the epidermal/dermal interface (bar=20 mm). (B) The mean distance of
LCs from the basement membrane in untreated and VLP-treated skin samples. (C) Representative examples of CD207+ve cells located in the skin
dermis (red arrows) 24 hours after ID injection of H1 VLPs (bar 50 mm).
doi:10.1371/journal.pone.0012410.g006
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changes and migration of LCs in response to vaccines are
confirmed in the human environment, as demonstrated for the
first time in this study for VLP vaccines. Monitoring cellular
changes in excised human skin can provide new functional and
mechanistic insight into the early human responses to vaccines,
providing a powerful tool in developing effective future vaccines.
Materials and Methods
Ethics Statement
Human skin samples were obtained from female patients
undergoing mastectomy or breast reduction surgery under
informed written patient consent and local ethical committee
approval (South East Wales Research Ethics Committees Panel C,
Reference: 08/WSE03/55).
Materials
Dulbecco’s modified Eagle medium (DMEM), fetal calf serum
(FCS) and penicillin/streptomycin were purchased from Invitro-
gen (Paisley, UK); all other items were purchased from Fisher
Scientific (Loughborough, UK) unless otherwise stated.
Collection, transport and processing of human skin
Excised human skin was transported from surgery to the
laboratory in culture media composed of 94% DMEM, 5% FCS
and 1% penicillin/streptomycin (each at 100 IU mL
21)a t4 uC.
Skin was prepared for treatment by removal of subcutaneous fat
tissue by blunt dissection before being pinned, dermis side down,
onto a cork dissection board. Treated regions and control
untreated regions of skin were excised, each approximately
0.560.5 cm, and cultured at the air-liquid interface at 37uC and
5% CO2 [31,44]. Data presented in this study was obtained from
numerous replicate samples performed in skin taken from two
independent patient donors.
ID injection of H1 VLP vaccines
Recombinant baculoviruses (BVs) expressing hemagglutinin
(HA) and matrix (M1) derived from A/PR/8/34 (H1N1) and
influenza VLPs containing HA and M1 were prepared as
described [45]. To produce influenza VLP vaccine, Sf9 insect
cells were co-infected with recombinant BVs expressing HA and
M1. Influenza VLPs in the culture supernatants were purified by
using discontinuous sucrose gradient layers, and characterized by
Western blot and hemagglutination activity analysis [37,45]. The
content of HA was approximately 10% of total proteins of
influenza VLPs, which is similar to that of a previous report
[37,45]. H1 VLPs (10ml of a 1mg/ml solution in PBS) were
injected into the dermal compartment of excised human skin. A
clear wheal following injection signaled correct positioning of the
needle for ID injection (Figure 1) [46]. Control samples received
an ID injection of 10ml of sterile PBS.
Monitoring changes in Langerhans cell numbers,
morphology and area in epidermal sheets
Cultured skin samples were incubated in 3.8% w/v ammonium
thiocyanate (Sigma-Aldrich chemical company, Poole, UK) in
PBS for 20–40 min. Epidermis was peeled away from the dermis
with forceps under a dissection microscope. Epidermal sheets were
fixed in pre-cooled acetone at 220uC for 20 min followed by
rinsing in PBS. Epidermal sheets were transferred into 1.5ml
centrifuge tubes and incubated in 0.03% v/v H2O2 for 5 min at
room temperature. Peroxide solution was removed and 1 ml of
PBS/Tween (0.01M PBS; 0.05% Tween-20 adjusted to pH 7.4)
was added for 3 min. This was removed and replaced a total of 3
times. The primary CD207 (Langerin) mouse monoclonal
Figure 7. Schematic depicting the proposed sequence of events leading to LC migration from skin epidermis. In normal skin LCs
display typical DC morphology, i.e. contain many dendritic protrusions. Upon activation LCs detach from surrounding keratinocytes and retract
dendrites assuming a ‘‘rounded’’ morphology. A point of attachment is made from which the LC subsequently moves, potentially in a chemotactic
manner, toward the basement membrane. Cells elongate to enable downward vertical movement.
doi:10.1371/journal.pone.0012410.g007
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incubated at room temperature for 1 hour. Sheets were rinsed in
three changes of 1 ml PBS/Tween, each for 3 min. Detection of
primary antibody was achieved with an EnVision+ system-HRP
(DAB) kit (Dako UK Ltd, Cambridgeshire, UK) used according to
manufacturers’ specifications. Stained sheets were spread out on
slides and visualized by light microscopy with representative
images captured digitally (Olympus, Watford, UK).
Image analysis of LC numbers, dendrite morphology and
area in epidermal sheets
Image analysis was performed with ImageJ software (available
at http://rsb.info.nih.gov/ij; developed by Wayne Rasband,
National Institutes of Health, Bethesda, MD). To determine cell
number, immunohistochemically stained epidermal sheets were
viewed at 620 magnification, corresponding to a field of view of
360 by 450 mm. Random images were captured from which the
cell number was counted and averaged. Area measurements and
dendrite morphology were determined from individual LCs
(n=100 for each treatment) at either 640 or 6100 magnification
from random fields of view.
Monitoring changes in distribution of LCs in histological
sections
Cultured skin samples were rinsed in PBS before fixation in
formalin for 24 hours. Samples were dehydrated in an ethanol
gradient and cleared in chloroform prior to incubation in two
changes of molten paraffin (56uC) before embedding in fresh
paraffin. Histological sections of 4mm were generated (Leica 2125
RT microtome, Milton Keynes, UK) and captured onto Super-
frostH Plus slides. Selected slides were rehydrated through an
ethanol gradient and subject to heat mediated antigen retrieval in
Tris-EDTA Buffer (10mM Tris base; 1mM EDTA; 0.05% v/v
Tween 20, in 1L ddH2O adjusted to pH 9.0) at approximately
95uC for 40 min; following which the slides were maintained in
antigen retrieval buffer but removed from heat and allowed to cool
for approximately 20 min, at room temperature. Slides were
washed in two changes of PBS-Tween before incubation in 0.03%
H2O2 for 5 min at room temperature. Detection and visualization
of CD207 was as for epidermal sheets.
Determination of area of LCs in sections and distribution
in relation to basement membrane
The percentage area occupied by LCs (CD207+ cells) in IHC
stained sections was determined relative to the total epidermal
area using ImageJ software.
Statistical analysis
Statistical tests comprised one-way analysis of variance
(ANOVA) followed by Tukey’s post hoc analysis performed using
MINITAB 13 software (Minitab Ltd., Coventry, UK).
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